Aktis Oncology, Inc.
AKTS
$25.00
$0.281.13%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 06/30/2025 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 517.32M | 538.48M | 226.79M | -- | |
| Total Receivables | 2.30M | 2.20M | 1.10M | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | 4.92M | 3.26M | 2.42M | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | |
| Total Current Assets | 524.54M | 543.94M | 230.31M | -- | |
|
|
|||||
| Total Current Assets | 524.54M | 543.94M | 230.31M | -- | |
| Net Property, Plant & Equipment | 28.20M | 28.11M | 27.25M | -- | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | 4.86M | 4.75M | 7.33M | -- | |
| Total Assets | 557.60M | 576.80M | 264.89M | -- | |
|
|
|||||
| Total Accounts Payable | 2.53M | 1.23M | 1.74M | -- | |
| Total Accrued Expenses | 10.78M | 6.30M | 9.52M | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | 1.48M | 1.43M | 1.32M | -- | |
| Total Finance Division Other Current Liabilities | 17.34M | 18.96M | 18.66M | -- | |
| Total Other Current Liabilities | 17.34M | 18.96M | 18.66M | -- | |
| Total Current Liabilities | 32.13M | 27.91M | 31.24M | -- | |
|
|
|||||
| Total Current Liabilities | 32.13M | 27.91M | 31.24M | -- | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | 9.76M | 10.15M | 10.23M | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | 30.87M | 32.63M | 36.16M | -- | |
| Total Liabilities | 72.76M | 70.69M | 77.63M | -- | |
|
|
|||||
| Common Stock & APIC | 684.62M | 681.24M | 10.37M | -- | |
| Retained Earnings | -199.03M | -174.89M | -156.56M | -- | |
| Treasury Stock & Other | -745.00K | -241.00K | 42.00K | -- | |
| Total Common Equity | 484.84M | 506.11M | -146.15M | -- | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | 333.41M | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | 333.41M | -- | |
|
|
|||||
| Total Common Equity | 484.84M | 506.11M | -146.15M | -- | |
| Total Preferred Equity | -- | -- | 333.41M | -- | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 484.84M | 506.11M | 187.26M | -- | |
|
|
|||||